Roche Chi­na CEO preps for a move to Mer­ck KGaA while US Mer­ck adds to C-suite; Suc­ces­sion plan fi­nal­ized for EVPs re­tir­ing from Sanofi

→ Be­gin­ning Oct. 1, Roche Chi­na CEO Hong Chow will be head of Chi­na & in­ter­na­tion­al for Mer­ck KGaA’s health­care busi­ness, a po­si­tion that al­so en­com­pass­es Japan, Eu­rope, Latin Amer­i­ca, Asia-Pa­cif­ic, the Mid­dle East, Africa and Rus­sia. The mul­ti-pronged po­si­tion al­so has Chow lead­ing the car­dio­vas­cu­lar me­tab­o­lism & en­docrinol­o­gy fran­chise and the Glob­al Busi­ness In­no­va­tion (GBI) unit. A Bay­er alum, Chow has helmed Roche Chi­na since 2015.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Life Sciences Senior Associate

General Catalyst

San Francisco, CA, USA